RT @CADarlow: This happens even with newer agents. In the clinical trials for testing meropenem-vaborbactam and cefidercol for HAP, whilst…
This happens even with newer agents. In the clinical trials for testing meropenem-vaborbactam and cefidercol for HAP, whilst both produced a successful trial outcome, emergence of resistance to both was seen in each trial. https://t.co/c6Komo2qlQ https://t
Fourth study was on clinical experience with meropenem/vaborbactam from Italy. Single center, prospective, observational. Limited data on its use after tango 2. @Sara_Alosaimy @ryankshields work got a shout out #ECCMID2023 https://t.co/FdBeyTTP6I https:/
RT @litalkat: לא דמי ייעוץ, מענקי מחקר ודמי הרצאה מפייזר. ובטח שלא תרומות. מעתה אמרו: "כל מיני הכנסות שהתפתחו לאנשים". לפחות עבור פרופ' גלי…
איפה כל אבירי הדמוקרטיה ,שלטון נקי כפיים ושות'? בטוחה שתדרשו לחקור
RT @litalkat: לא דמי ייעוץ, מענקי מחקר ודמי הרצאה מפייזר. ובטח שלא תרומות. מעתה אמרו: "כל מיני הכנסות שהתפתחו לאנשים". לפחות עבור פרופ' גלי…
RT @ArnonGro: @YaffaRaz @BonehElad נו, נו, ומי עוד קיבלה דמי ייעוץ, מענקים ושכר הרצאה מפייזר? https://t.co/uYwjBQZspS https://t.co/JxATmroR…
@talfriedman1 @Rereshef @mulisegev @DavidLifshitz גליה הזאת? שמקבלת כספים מפייזר? https://t.co/MKwTQSb8Yv
RT @ArnonGro: @YaffaRaz @BonehElad נו, נו, ומי עוד קיבלה דמי ייעוץ, מענקים ושכר הרצאה מפייזר? https://t.co/uYwjBQZspS https://t.co/JxATmroR…
RT @litalkat: לא דמי ייעוץ, מענקי מחקר ודמי הרצאה מפייזר. ובטח שלא תרומות. מעתה אמרו: "כל מיני הכנסות שהתפתחו לאנשים". לפחות עבור פרופ' גלי…
לא דמי ייעוץ, מענקי מחקר ודמי הרצאה מפייזר. ובטח שלא תרומות. מעתה אמרו: "כל מיני הכנסות שהתפתחו לאנשים". לפחות עבור פרופ' גליה רהב זה #יעיל_ובטוח
@YaffaRaz @BonehElad נו, נו, ומי עוד קיבלה דמי ייעוץ, מענקים ושכר הרצאה מפייזר? https://t.co/uYwjBQZspS https://t.co/JxATmroR8A
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial - our 3rd most cited article of 2021! https://t.co/XQuxRaLk6l #CRE #Antimic
@emilylheil 2 - Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial https://t.co/OWRIFBDMJ1 #vabomere @Keith_S_Kaye https://t.c
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
During #OpenAccessWeek, read the top downloaded articles in Infectious Diseases and Therapy this year: Tango II trial: https://t.co/KtXvLT70HF Dalbavancin use in vulnerable patients: https://t.co/456KOlrnSE NAFLD and HIV review: https://t.co/uO24IF5d2
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
Thanks
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @DocWoc71: Great talk done by @davidvanduin in the session #ClinicalTrials in #BacterialDisease love the slides #IDWeek2019 https://t.co…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
Oral step-down for endocarditis, RIP colistin #ivtooral #antibiotics #asp #antibioticos #PROA #antibioticresistance #AntibioticResistance #antimicrobialresistance
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @KisgenUF: 👇This! Probably the most informational tweet from #IDWeek. Thanks for sharing! #IDTwitter https://t.co/Cmm3ZIVW1Y
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @mscondetoledo: Estudios que cambian la práctica clínica #IDWeek2019 https://t.co/l67yxVVBVE
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
This is a great summary!
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…
RT @CalderwoodMD: Clinical trials that might change your practice #IDWeek: https://t.co/TqnaGDm0RK, https://t.co/L71XnZKpAj, https://t.co/Y…